Prestige Consumer Healthcare
PBH
#3924
Rank
A$4.61 B
Marketcap
A$95.90
Share price
1.19%
Change (1 day)
-31.03%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): A$6.36

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.87. In 2024 the company made an earnings per share (EPS) of A$6.22 an increase over its 2023 EPS that were of A-$2.33.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$6.362.23%
2024A$6.22-367.08%
2023A-$2.33-138.33%
2022A$6.0711.7%
2021A$5.4413.6%
2020A$4.79-651.67%
2019A-$0.87-148.78%
2018A$1.78-83.29%
2017A$10.64437.23%
2016A$1.98-34.13%
2015A$3.0152.94%
2014A$1.97-8.11%
2013A$2.14
2011A$1.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.09 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$10.16 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.64 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$2.49-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.65 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$9.27 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$0.58-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.20-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$42.83-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.76-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel